Vanguard Group Inc Adma Biologics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,198,796 shares of ADMA stock, worth $335 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,198,796

Previous 18,118,494 0.44%

Holding current value

$335 Million

Previous $362 Million 13.83%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$15.62 - $22.62 $1.25 Million - $1.82 Million	80,302 Added 0.44%	18,198,796 $312 Million
Q3 2024 Nov 13, 2024	BUY	$11.21 - $20.03 $40.4 Million - $72.1 Million	3,601,842 Added 24.81%	18,118,494 $362 Million
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $10.9 Million - $20.4 Million	1,827,258 Added 14.4%	14,516,652 $162 Million
Q1 2024 May 10, 2024	SELL	$4.4 - $6.74 $890,916 - $1.36 Million	-202,481 Reduced 1.57%	12,689,394 $83.8 Million
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $339,354 - $498,013	110,180 Added 0.86%	12,891,875 $58.3 Million
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $1.17 Million - $1.55 Million	336,190 Added 2.7%	12,781,695 $45.8 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $1.98 Million - $2.67 Million	633,878 Added 5.37%	12,445,505 $45.9 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $2.81 Million - $3.61 Million	932,968 Added 8.58%	11,811,627 $39.1 Million
Q4 2022 Feb 10, 2023	BUY	$2.47 - $3.88 $3.92 Million - $6.16 Million	1,587,960 Added 17.09%	10,878,659 $42.2 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $508,423 - $716,301	250,455 Added 2.77%	9,290,699 $22.6 Million
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $1.29 Million - $1.98 Million	901,824 Added 11.08%	9,040,244 $17.9 Million
Q1 2022 May 13, 2022	SELL	$1.28 - $1.83 $442,419 - $632,521	-345,640 Reduced 4.07%	8,138,420 $14.9 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $3.01 Million - $4.58 Million	2,760,709 Added 48.24%	8,484,060 $12 Million
Q3 2021 Nov 12, 2021	BUY	$1.13 - $1.65 $128,968 - $188,316	114,131 Added 2.03%	5,723,351 $6.47 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.07 $8.47 Million - $11.6 Million	5,609,220 New	5,609,220 $8.98 Million

Others Institutions Holding ADMA

# of Institutions

339

Shares Held

182M

Call Options Held

1.72M

Put Options Held

846K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.62B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Adma Biologics, Inc. Transaction History